http://orcid.org/0000-0002-2934-5382
References
- Baeten, J. M., Heffron, R., Kidoguchi, L., Mugo, N. R., Katabira, E., Bukusi, E. A., … Siegfried, N. (2016). Integrated delivery of antiretroviral treatment and Pre-exposure prophylaxis to HIV-1-serodiscordant couples: A prospective implementation study in Kenya and Uganda. PLoS Medicine, 13(8), e1002099. doi: 10.1371/journal.pmed.1002099
- Byrt, T., Bishop, J., & Carlin, J. B. (1993). Bias, prevalence and kappa. Journal of Clinical Epidemiology, 46(5), 423–429. doi: 10.1016/0895-4356(93)90018-V
- Centers for Disease Control and Prevention. (2014). Preexposure prophylaxis for the prevention of HIV infection in the United States – 2014 clinical practice guideline. Retrieved from http://www.cdc.gov/hiv/pdf/prepguidelines2014.pdf
- Escudero, D. J., Lurie, M. N., Kerr, T., Howe, C. J., & Marshall, B. D. (2014). HIV pre-exposure prophylaxis for people who inject drugs: A review of current results and an agenda for future research. Journal of the International AIDS Society, 17, 18899. doi: 10.7448/IAS.17.1.18899
- Hoehler, F. K. (2000). Bias and prevalence effects on kappa viewed in terms of sensitivity and specificity. Journal of Clinical Epidemiology, 53(5), 499–503. doi: 10.1016/S0895-4356(99)00174-2
- Holt, M., Murphy, D. A., Callander, D., Ellard, J., Rosengarten, M., Kippax, S. C., & de Wit, J. B. (2012). Willingness to use HIV pre-exposure prophylaxis and the likelihood of decreased condom use are both associated with unprotected anal intercourse and the perceived likelihood of becoming HIV positive among Australian gay and bisexual men. Sexually Transmitted Infections, 88(4), 258–263. doi: 10.1136/sextrans-2011-050312
- Ko, N. Y. (2016). From evidence to health policy making: Pre-exposure prophylaxis for HIV prevention. Hu li za zhi The Journal of Nursing, 63(6), 18–22. doi:10.6224/JN.63.6.18
- Koechlin, F. M., Fonner, V. A., Dalglish, S. L., O’Reilly, K. R., Baggaley, R., Grant, R. M., … Kennedy, C. E. (2016). Values and preferences on the use of oral pre-exposure prophylaxis (PrEP) for HIV prevention among multiple populations: A systematic review of the literature. AIDS and Behavior. doi: 10.1007/s10461-016-1627-z
- Koechlin, F. M., Fonner, V. A., Dalglish, S. L., O’Reilly, K. R., Baggaley, R., Grant, R. M., & Kennedy, C. E. (2017). Values and preferences on the use of oral pre-exposure prophylaxis (PrEP) for HIV prevention among multiple populations: A systematic review of the literature. AIDS and Behavior, 21(5), 1325–1335. doi: 10.1007/s10461-016-1627-z
- Page, K., & Bacon, O. (2017). Commitment issues: PrEP adherence in injecting drug users. The Lancet HIV, 4(2), e52–e53. doi: 10.1016/S2352-3018(16)30208-9
- Peng, P., Su, S., Fairley, C. K., Chu, M., Jiang, S., Zhuang, X., & Zhang, L. (2017). A global estimate of the acceptability of Pre-exposure prophylaxis for HIV among men who have sex with men: A systematic review and meta-analysis. AIDS and Behavior, 22, 1063–1074. doi: 10.1007/s10461-017-1675-z
- Taiwan Centers for Disease Control. (2017). Updated HIV/AIDS statistics in Taiwan. Retrieved from https://www.cdc.gov.tw/english/info.aspx?treeid=00ED75D6C887BB27&nowtreeid=2FA0168FF47E02BE&tid=383C11424311E133
- WHO. (2015). Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva. Retrieved from http://www.who.int/hiv/pub/guidelines/earlyrelease-arv/en/
- WHO. (2016). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach (2nd ed.). Geneva: Author.
![Supercharge Your Next Research Paper: Research and write your next paper with Jenni AI.]({"type":"image" , "src" : "/sda/112442/MPU-social-sciences.png"})